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Abstract
Objective: Metabolic syndrome (MS) is a group of risk factors which includes hypertension, hyperglycemia,
abnormal cholesterol levels, and obesity. Red blood cell distribution width (RDW) is a parameter that reflects
the heterogeneity of erythrocyte volume. But the relationship between MS and RDW is intricate and remains
poorly understood. We hypothesized that high RDW was associated with MS via inflammation. Our study
aimed to investigate the association between RDW and MS in Chinese elderly large cohort. If RDW had a
strong correlation with MS, RDW could become a predictor of MS?
Methods: We recruited 10,887 ostensibly healthy participants aged from 60 to 93 (5795 male, 5092 female).
Associations between RDW and other variables were assessed by Pearson correlation. Crude and adjusted
odds ratio for MS with 95% confidence intervals was calculated by binary logistic regression models.
Results: In elderly Chinese, RDW was significantly higher in males than in females. The prevalence of both
men and women decreased with the rise of RDW. For both sexes, RDW demonstrated positive correlations
with age, systolic blood pressure (0.070 in males,0.058 in females), high density lipoprotein(0.027in males,0.064
in females), negative correlations with triglycerides (− 0.120 in males,-0.074 in females) and fasting glucose (− 0.048 in
males,-0.016 in females). Notably, we detected the associated reduced risks at the the third and fourth quartile of RDW
in males. In women, there was no statistical significance.
Conclusion: We found the adjusted odds ratios of MS was lower at the third and fourth quartile of RDW in males.
Keywords: Red blood cell distribution width (RDW), Metabolic syndrome (MS), Gender, Age
Introduction
Recently, high incidence of metabolic syndrome (MS)
has been demonstrated by epidemiological studies in the
Chinese elderly population [1]. MS is a group of risk fac-
tors, which include hypertension, hyperglycemia, abnor-
mal cholesterol levels, and obesity. A joint statement
about MS definition consensus standards was published
in 2009 [2]. MS is actually a chronic inflammatory dis-
ease [3]. Moreover, risks for patients diagnosed with MS
include higher incident and mortality of cardiovascular
events and ischemic stroke [4, 5]. Red blood cell distri-
bution width (RDW) is a parameter that reflects the
heterogeneity of erythrocyte volume. RDW is an inex-
pensive, non-invasive and powerful indicator that is as-
sociated with inflammation [6]. Several studies have
shown that high RDW was associated with MS, but
there are still a lot of inconsistencies [7–15], such as the
correlation between RDW and MS diagnostic criteria
and the relationship between RDW and hypertension or
obesity. The incidence of MS marker increased after
menopause onset in the female population [16]. We hy-
pothesized that high RDW was associated with MS via
inflammation. Besides, no previous study has looked
through this matter in different gender perspective.
Therefore, the purpose of this cross-sectional study was
to inspect correlations between RDW and MS and
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focused on the difference of gender in an elderly popula-
tion from Tianjin. If approved, it will endorse the poten-
tiality of considering RDW as one predictor of MS.
Subjects and methods
Design
We have been conducting this cross-sectional,
community-based health-check research for more
than a decade, under collaboration from the depart-
ments of Health Management, Ultrasound, and Nu-
clear Medicine from Tianjin Medical University
General Hospital [17–24]. During the period from
September 2007 to September 2013, a total of 10,887
eligible subjects (5795 male, 5092 female) who aged
over 60 years took part in this community-based
health examination program. First, all participants
completed a self-report questionnaire and were asked
to provide a blood sample, then received an overall
heath check. In order to avoid the influence of
confounding factors, exclusion criteria were used for
the following situations: participants suffering from
hematological, infectious or inflammatory disease; par-
ticipants with liver diseases; participants with previous
histories of ischemic heart disease or stroke, treat-
ment with hematological drugs, thromboembolism or
immunological diseases; subjects with any diseases or
taking any medicine that might affect red blood cell
(RBC); pregnancy. (Fig. 1).
Ethics
The institutional review board and ethic committee of
Tianjin Medical University General Hospital approved
the ethical, methodological and protocol aspects of this
investigation. We confirm that all methods in the
current study were carried out in accordance with the
relevant guidelines and regulations. All participants in
this research provided their written consents. The ethical
approval number was 2011-6-1.
Measurements
Anthropometric measurements and fasting blood tests
of every participant were performed during the partici-
pants’ visits to our institution. The time between blood
sampling and RDW measurement was controlled within
three hours. Body height (BH) and body weight (BW)
were measured in centimeters and kilograms. Body mass
index (BMI) was calculated by dividing BW (kilograms)
by the square of BH (meters2). Blood pressure was mea-
sured by using a sphygmomanometer. High density lipo-
protein (HDL), low density lipoprotein (LDL), total
cholesterol (TC), triglycerides (TG), triglycerides (FG),
blood urea nitrogen (BUN) and total bilirubin (TBIL)
were measured by an auto-analyzer (Hitachi Corpor-
ation, Tokyo, Japan); C-reactive protein (CRP) were mea-
sured by an analyzer (Hebai Diagnostics, Shijiazhuang,
China); erythrocyte sedimentation rate (ESR) by Wes-
tergren method (Fabraeus, Sweden); mean corpuscular
volume (MCV), mean corpuscular hemoglobin (MCH),
mean corpuscular hemoglobin concentration (MCHC),
RBC, hemoglobin (HB) and RDW by a hemocytometer
analyzer (Sysmex Corporation, Kobe, Japan).
The laboratory calibration references for parameters were
as follows: HDL 0.80–2.20mmol/L; LDL 1.33–3.36mmol/
L; TC 3.59–5.17mmol/L; TG 0.57–1.70mmol/L; FG 3.60–
5.80mmol/L; BUN 1.70–8.30mmol/L; TBIL 3.40–
20.00 μmol/L; CRP < 8mg/L; ESR 0–20mm/hr.; MCV
80-97 fL; MCH 26.5–33.5 pg; MCHC 315-350 g/L; RBC
3.8–5.1 × 1012/L; HB 3.5–5.5× 1012 g/L; RDW10.0–15.0%.
Fig. 1 Flow chart. Was a description of the participant’s experimental process
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Definitions
MS was diagnosed by current guidelines, in particular,
diagnosis was determined when at least three of the fol-
lowings criteria were met [2]: (1) Waist > 90 cm in men, >
80 cm in women; (2) TG > 1.70mmol/L; (3) HDL < 1.03
mmol/L in men, < 1.29mmol/L in women; (4) Systolic
blood pressure (SBP) ≥ 130mmHg or diastolic blood pres-
sure (DBP) ≥ 85mmHg, and (5) FG ≥ 5.60mmol/L.
Statistical analysis
Population characteristics as well as clinical parameters
were presented by mean ± standard deviation, both in
total and by gender groups. We divide the data into two
groups of male and female for analysis. We used inde-
pendent sample’s t-test to analysis the differences of in-
dices. Pearson bivariate correlation was used to explore
the relationships among RDW and other variables.
RDW concentrations were divided into quartiles. Then
we compared inter-group prevalence differences MS by
using Chi-square test. We compared the relationship be-
tween other variables and MS. We performed the T-test
between the parameters of the MS groups and the nor-
mal. Crude as well as adjusted odds ratio (OR) for MS
with 95% confidence intervals (CI) was calculated by
binary logistic regression models. P value of less than
0.05 was considered as statistically significant. Statistical
Package for Social Sciences (SPSS version 17.0, Chicago,
IL) was used to carry out statistics. Significance was de-
fined as P < 0.05.
Result
Characteristics of the participants in different genders
There were significant differences in parameters with
respect to opposite sex. Except for age, BMI, CRP,
there were significant differences in the characteristics
of participants with respect to opposite gender
(Table 1). Overall, waist, DBP, FG, BUN, TBIL, MCV,
MCHC, RBC, HB, WBC(white blood cell) and RDW
were significantly higher in men than in women. SBP,
HDL, LDL, TC, TG, ESR MCH were lower in males
than in females.
Table 1 Population characteristics based on different genders
Total Male Female T value P value
Case number 10,887 5795 5092
Age (years) 67.92 ± 5.78 67.79 ± 5.94 68.00 ± 5.68 −1.879 0.060
BMI (kg/m2) 25.69 ± 3.43 25.75 ± 3.00 25.65 ± 3.65 1.592 0.111
Waist (cm) 87.93 ± 9.61 91.18 ± 8.70 86.08 ± 9.62 29.011** 0.000
SBP (mmHg) 138.68 ± 18.53 137.08 ± 18.20 139.59 ± 18.65 −7.100** 0.000
DBP (mmHg) 80.15 ± 10.42 82.59 ± 10.57 78.76 ± 10.08 19.264** 0.000
HDL (mmol/L) 1.45 ± 0.37 1.31 ± 0.32 1.53 ± 0.36 −33.727** 0.000
LDL (mmol/L) 3.40 ± 0.91 3.19 ± 0.83 3.52 ± 0.93 −19.976** 0.000
TC (mmol/L) 5.56 ± 1.04 5.18 ± 0.93 5.77 ± 1.03 −31.161** 0.000
TG (mmol/L) 1.58 ± 0.78 1.54 ± 0.79 1.60 ± 0.78 −3.784** 0.000
FG (mmol/L) 5.48 ± 1.02 5.56 ± 1.06 5.44 ± 0.99 6.084** 0.000
BUN (mmol/L) 5.20 ± 1.33 5.41 ± 1.37 5.08 ± 1.30 13.116** 0.000
TBIL (μmol/L) 12.33 ± 4.64 13.82 ± 5.06 11.49 ± 4.15 26.029** 0.000
CRP (mg/L) 0.65 ± 1.74 0.75 ± 2.54 0.59 ± 0.94 1.637 0.102
ESR (mm/hr) 6.53 ± 3.47 4.98 ± 2.31 7.53 ± 3.71 −32.221** 0.000
MCV (fL) 81.82 ± 21.46 83.29 ± 20.26 80.98 ± 22.07 5.675** 0.000
MCH (pg) 73.29 ± 105.02 68.50 ± 99.89 76.02 ± 107.73 −3.780** 0.000
MCHC(g/L) 286.18 ± 113.95 295.22 ± 108.82 281.03 ± 116.46 6.570** 0.000
RBC (×1012/L) 4.59 ± 0.37 4.88 ± 0.32 4.42 ± 0.28 78.690** 0.000
HB (g/L) 138.13 ± 11.29 148.92 ± 8.68 131.99 ± 7.29 109.328** 0.000
RDW (%) 12.73 ± 0.79 12.89 ± 0.79 12.64 ± 0.78 16.732** 0.000
WBC(×1012/L) 5.58 ± 1.18 5.82 ± 1.20 5.45 ± 1.14 16.470** 0.000
BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, HDL high density lipoprotein, LDL low density lipoprotein, TC total cholesterol, TG
triglycerides, FG fasting glucose, BUN blood urea nitrogen, TBIL total bilirubin, CRP C-reactive protein, ESR erythrocyte sedimentation rate, MCV mean corpuscular
volume, MCH mean corpuscular hemoglobin, MCHC mean corpuscular hemoglobin concentration, RBC red blood cell, HB hemoglobin, RDW red blood cell distribution
width, WBC white blood cell
* P < 0.05, ** P < 0.01 (analyzed by independent sample’s t test)
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Prevalence of MS according to RDW quartiles
On the whole, the incidence of MS was significantly
lower in males (39.74%, 3492 out of 5795 cases) than in
female (47.55%, 4671 out of 5092 cases), with a
Chi-square value of 67.202 (P < 0.01). With the rise of
RDW quartiles, the prevalence of MS decreased in males
and females (Table 2), but not statistically significant
among women.
Correlations between RDW and other key variables on
different genders
RDW demonstrated positive correlations with age, SBP,
HDL, LDL, TC, BUN, MCH and RBC, negative correla-
tions with BMI, TG, FG, MCV, MCHC and HB in males.
RDW displayed positive correlations with age, SBP,
HDL, LDL, TC, TBIL and MCH, negative correlations
with TG, FG, MCV, MCHC and HB in females. For both
sexes, no obvious correlations were identified between
RDW and waist, DBP or CRP (Table 3).
Differences between different variables in the MS groups
and the normal based on different genders
BMI, TC, BUN, RBC, WBC and HB had significant dif-
ferences in MS groups and the normal in both sexes.
Different, MS was associated with TBIL and MCHC in
males, MS was associated with LDL, MCV and ESR in
females (Table 4).
The risks of MS according to RDW quartiles in different
genders
The risks of developing MS were calculated by binary lo-
gistic regression models in different genders with the
lowest RDW quartile as reference (Table 5). Adjusted
risk factors included age, BMI, TC, LDL, RBC, HB,
TBIL, BUN, MCV, WBC and MCHC in both sexes. In
males, we demonstrated significantly reduced risks of
MS while RDW increased from the basic level. The risk
of MS was lower at the third and fourth quartile of
RDW, indicating protective effects of high RDW against
MS. In females, the risk of MS and RDW was not statis-
tically significant.
Discussion
Recently, the incidence of MS increased quickly, espe-
cially in the elderly population. MS is a determinate fac-
tor which increases the risk of cardiovascular diseases
and ischemic stroke [4, 5]. RDW is a measurement of
the width of the RBC variable in the blood count report,
as a diagnostic marker for anemia [25]. RDW may be an
indicator of oxidative stress and underlying inflamma-
tion in patients with Chronic Obstructive Pulmonary
Disease (COPD) [26]. RDW is also an inflammatory
marker used to predict the potential risk of cardiovascu-
lar events and it may be associated with the develop-
ment of postoperative atrial fibrillation after elective
on-pump cardiac surgery as presented [10, 27]. RDW
may be associated with albuminuria in familial Mediter-
ranean fever patients and it can be a predictor of micro-
albuminuria [28]. RDW could be deduced by the
percentage ratio of the difference in mean corpuscular
volume and mean corpuscular volume.
Some studies have explored the relationship between
RDW and MS, trying to explain the underlying reason.
But, controversy exists. Sanchez-Chaparro et al. [11]
found that high RDW reflected an inflammatory state,
resulting in impaired erythrocyte maturation and aniso-
cytosis. However, the sample of the study was mostly
composed of a young healthy Spanish population in an
active working situation. They were not good enough to
represent the general population. The study of Farah et
al. [8] indicated that RDW was positively correlated with
MS, and RDW increased with the severity of MS. The
limitation of this study was that the number of samples
(300 subjects) was too small to carry out subgroup ana-
lysis. In 2011, Vaya et al. [14] pointed out that abdominal
obesity was the only MS component associated with
Table 2 Prevalence of metabolic syndrome on different genders
Prevalence (and case number count) in different RDW quartiles
Quartile 1 Quartile 2 Quartile 3 Quartile 4 Total Chi-square value(P)
Male
Normal 55.72%(931) 58.04%(863) 61.82%(787) 66.79%(911) 60.26%(3492) 43.060**(0.000)
Metabolic syndrome 44.28%(740) 41.96%(624) 38.18%(486) 33.21%(453) 39.74%(2303)
Female
Normal 50.34%(659) 51.59%(649) 53.44%(776) 54.71%(587) 52.45%(2671) 5.467(0.141)
metabolic syndrome 49.66%(650) 48.41%(609) 46.56%(676) 45.29%(486) 47.55%(2421)
Chi-square value(P) 8.509**(0.004) 11.446**(0.001) 19.470**(0.000) 37.017**(0.000) 67.202**(0.000)
RDW red blood cell distribution width
Metabolic syndrome diagnosed when at least three of the followings criteria were met: (1) Waist ≥90 cm in men, ≥ 80 cm in women, (2) TG ≥ 1.70 mol/L, (3) HDL
< 1.03 mmol/L in men, < 1.29 mmol/L in women, (4) SBP ≥ 130 mmHg or DBP ≥ 85 mmHg, and (5) FG ≥ 5.60 mmol/L.
* P < 0.05, ** P < 0.01 (analyzed by Chi-square test)
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high RDW. However, Fujita et al. [9] concluded that
obesity was not necessarily positively correlated with
RDW through animal models. Laufer et al. [29] demon-
strated that high RDW (RDW ≥ 14%) was associated
with increased risk of MS and long-term mortality,
which also showed that hypertension was the strongest
risk factor with RDW ≥ 14% in all criteria for MS. These
results were not in good conformity with the study from
Vaya et al. [14]. In addition, a different point of view
raised in the study of Emamian et al. [7] was that level
of RDW was higher among normotensive individuals
than hypertensive. Perhaps, the role of gene deletions
and gene polymorphisms in regulating hypertension in
different populations can partially explain the divergence
[30–34]. Vaya et al. [15] suggested that RDW had no re-
lationship with an unfavorable lipid profile in the normal
population. But Tsuda et al. [12] indicated that MS was
associated with elevated levels of lipids, glucose levels
and circulating insulin levels to lead to reduce red blood
cell deformability through the impact on the erythrocyte
membrane. In another study of 137 metabolic patients
by Vaya et al. [13], red blood cell deformability was
negatively correlated with TG and glucose levels, posi-
tively correlated with RDW. The author indicated that
higher anisocytosis was associated with greater morpho-
logic alterations (shape/volume), which reduced erythro-
cyte deformability. The paper also proposed that
proinflammatory profile in metabolic patients could be
related to the positive association of RDW.
Why RDW can be somehow related with MS, even
though inconsistency exists? Firstly, hyperglycemia could
be one crucial reason behind this phenomenon. Insulin
resistance leading to impaired glucose tolerance can be
regarded as an important risk factor for MS. A study of
subjects aged 45 to 73 years followed over a mean time
of 14 years confirmed that low RDW was associated with
increased risk of developing diabetes mellitus [35]. RDW
is negatively correlated with waist and FG, insulin and
TG concentrations. Engstrom et al. [35] thought that
low RDW could be a marker of reduced RBC survival.
High blood sugar is associated with reduced changes in
mechanical properties and deformability of the RBC [36,
37]. Elevated blood sugar can affect RBC performance,
reduce RBC survival and create a more homogenous
population of cells. Thus, it can be deduced to explain
the increased risk of diabetes mellitus in patients with
low RDW. Secondly, it can also be speculated that the
reported relationship between high RDW, heart failure
Table 3 Pearson bivariate correlations between RDW and other variables based on different genders
Correlation coefficients for males(P) Correlation coefficients for females(P)
Age (years) 0.139**(0.000) 0.135**(0.000)
BMI (kg/m2) − 0.037*(0.004) − 0.016(0.254)
Waist (cm) 0.025(0.054) −0.019(0.055)
SBP (mmHg) 0.070**(0.000) 0.058**(0.000)
DBP (mmHg) −0.003(0.831) 0.002(0.820)
HDL (mmol/L) 0.027*(0.039) 0.064**(0.000)
LDL (mmol/L) 0.079**(0.000) 0.060**(0.000)
TC (mmol/L) 0.037**(0.005) 0.050**(0.000)
TG (mmol/L) −0.120**(0.000) − 0.074**(0.000)
FG (mmol/L) −0.048**(0.000) −0.016**(0.000)
BUN (mmol/L) 0.068**(0.000) 0.002(0.859)
TBIL (μmol/L) 0.015(0.255) 0.057**(0.000)
CRP (mg/L) −0.011(0.726) −0.014(0.686)
ESR (mm/hr) −0.017(0.324) 0.000(0.979)
MCV (fL) −0.084**(0.000) −0.099**(0.000)
MCH (pg) 0.074**(0.000) 0.093**(0.000)
MCHC(g/L) −0.088**(0.000) −0.108**(0.000)
RBC (×1012/L) 0.042**(0.001) 0.011(0.422)
HB (g/L) −0.045**(0.001) −0.081**(0.000)
WBC(×1012/L) 0.070** (0.000) 0.012 (0.239)
RDW red blood cell distribution width, BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, HDL high density lipoprotein, LDL low
density lipoprotein, TC total cholesterol, TG triglycerides, FG fasting glucose, BUN blood urea nitrogen, TBIL total bilirubin, CRP C-reactive protein, ESR erythrocyte
sedimentation rate, MCV mean corpuscular volume, MCH mean corpuscular hemoglobin, MCHC mean corpuscular hemoglobin concentration, RBC red blood cell,
HB hemoglobin, WBC white blood cell
* P < 0.05, ** P < 0.01
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and mortality may be related to the properties and
functions of senescent RBCs. In addition, Vaya et al.
[13] hypothesized that several factors which influence
erythrocyte deformability and RDW could be involved
in the relationship between RDW and metabolic traits,
and that their combined effects might be the cause of
these apparently incongruent results. In this sense, the
cholesterol content of the erythrocyte membrane
might play a role as an increase in this factor has been
found to be related with high RDW values. Thirdly,
perhaps, gene deletions and gene polymorphisms in
regulating MS in different populations can partially
explain the divergence between RDW and MS. For in-
stance, Rouskas et al. [38] indicated that genetic vari-
ation in the MKKS gene may occupy a position in the
development of MS.
Our study focused on the association between RDW
and MS among an elderly population in different sexes.
The incidence of MS in these post-menopausal women
was higher than in men. With the rise of RDW quartiles,
the incidence of MS decreased. The risk of MS was
lower at the higher quartiles of RDW in males. In fe-
males, there was no significant correlation between
RDW and the risk of MS risk. Wang et al. [17] con-
firmed that the prevalence of MS in young men was sig-
nificantly higher than that in women, and women had
higher MS prevalence than men after menopause period.
This finding was consistent with our research.
Several limitations of our research should be noted.
First, as a cross-sectional survey, we could not deter-
mine causality. Therefore, it is necessary to carry out a
study with prospective nature in the future. Second, the
Table 4 Differences between different variables in the MS groups and the normal based on different genders
Gender male female
Mean (SD) T value P value Mean (SD) T value P value
BMI Normal 24.77 (2.84) − 33.533** 0.000 24.46 (3.43) −36.812** 0.000
MS 27.24 (2.60) 26.97 (3.43)
LDL Normal 3.18 (0.81) − 0.563 0.574 3.47 (0.87) −6.481** 0.000
MS 3.19 (0.86) 3.59 (0.99)
TC Normal 5.15 (0.90) −3.269** 0.001 5.71 (0.96) −5.489** 0.000
MS 5.23 (0.98) 5.83 (1.10)
BUN Normal 5.37 (1.33) −3.202** 0.001 5.04 (1.23) −3.329** 0.001
MS 5.49 (1.42) 5.12 (1.37)
TBIL Normal 14.02 (5.15) 3.790** 0.000 11.52 (4.15) 0.750 0.453
MS 13.51 (4.02) 11.46 (4.14)
CRP Normal 0.73 (2.63) −0.216 0.829 0.55 (0.78) −1.757 0.079
MS 0.77 (2.41) 0.63 (1.07)
ESR Normal 4.98 (2.34) 0.274 0.850 7.68 (3.70) 3.305** 0.002
MS 5.00 (2.42) 7.36 (3.72)
MCV Normal 83.17 (20.81) −0.532 0.595 81.64 (21.84) 3.172 0.002
MS 83.46 (19.39) 80.26 (22.31)
MCH Normal 70.53 (101.86) −1.901 0.057 74.25 (105.74) −1.746 0.081
MS 65.43 (96.79) 77.99 (109.86)
MCHC Normal 296.38 (111.11) −2.441 0.015 282.50 (114.50) 1.337 0.181
MS 299.52 (105.13) 279.41 (118.57)
RBC Normal 4.85 (0.31) −7.252** 0.000 4.38 (0.28) −15.759** 0.000
MS 4.91 (0.33) 4.47 (0.28)
HB Normal 148.46 (8.44) −4.922** 0.000 131.08 (7.17) −13.359** 0.000
MS 148.61 (9.00) 133.00 (7.29)
WBC Normal 5.66 (1.18) −12.301** 0.000 5.23 (1.09) −14.960** 0.000
MS 6.05 (1.20) 5.69 (1.15)
BMI body mass index, LDL low density lipoprotein, TC total cholesterol, BUN blood urea nitrogen, TBIL total bilirubin, CRP C-reactive protein, ESR erythrocyte
sedimentation rate, MCV mean corpuscular volume, MCH mean corpuscular hemoglobin, MCHC mean corpuscular hemoglobin concentration, RBC red blood cell,
HB hemoglobin, WBC white blood cell
* P < 0.05, ** P < 0.01 (analyzed by independent sample’s t test)
Yan et al. Lipids in Health and Disease           (2019) 18:34 Page 6 of 9
blood parameters were checked only once, no repeated
measurements were performed. Third, due to the large
sample size, greater heterogeneity of the population
could affect the results we got. Fourth, while the exclu-
sion criteria were strictly used to eliminate diseases that
may affect parameters of this research, the health status
of some seemingly healthy participants might not be
known, which could be an interfering factor leading to
an error. Fifth, serum levels of other factors (iron, vita-
min B12, folic acid, Hemoglobin A1C), respiratory
condition and inflammatory markers, were not measured
in this study, which could affect RDW. Fifth, as a
single-center study, extra caution need to be made on its
generalizability.
Conclusion
We found the incidence of MS in males is higher than
that in females. There were significant correlations be-
tween multiple factors in the diagnostic criteria for MS
and RDW in different genders. RDW demonstrated posi-
tive correlations with SBP, HDL, negative correlations
with TG and FG. The risk of MS was lower at the high-
est quartile of RDW in males. There was no significant
statistical significance in females. At present, the inci-
dence of MS in the elderly is increasing year by year. But
the relationship between RDW and MS has not been
confirmed through relevant research about the elderly
Asian. Further investigations are needed to determine
whether the relationship becomes apparent.
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Table 5 The risks of metabolic syndrome according to RDW quartiles in different genders
Males Females
Parameter values Crude OR (CI) ^ Adjusted OR (CI) $ Parameter values Crude OR (CI) ^ Adjusted OR (CI) $
RDW ≤12.50 (reference) RDW ≤12.20 (reference)
12.50 < RDW ≤12.90 0.910 (0.790–1.048) 0.901 (0.769–1.057) 12.20 < RDW ≤12.60 0.951 (0.815–1.111) 1.006 (0.850–1.190)
12.90 < RDW ≤13.30 0.777 (0.670–0.901)* 0.764 (0.644–0.905)* 12.60 < RDW ≤13.10 0.883 (0.760–1.026)* 0.833 (0.749–1.041)
RDW > 13.30 0.626 (0.539–0.726)* 0.560 (0.471–0.666)* RDW > 13.10 0.839 (0.714–0.987)* 0.853 (0.712–1.022)
BMI 1.399 (1.365–1.43)* 1.233 (1.200–1.247)*
LDL 0.498 (0.413–0.601)* 1.032 (0.858–1.240)
TC 2.039 (1.725–2.411)* 1.097 (0.929–1.296)
WBC 1.257 (1.194–1.322)* 1.301 (1.231–1.375)*
Age 1.038 (1.027–1.049)* 1.034 (1.022–1.046)*
RDW red blood cell distribution width, OR odds ratio, CI confidence interval
Metabolic syndrome diagnosed when at least three of the followings criteria were met: (1) Waist ≥90 cm in men, ≥ 80 cm in women, (2) TG ≥ 1.70 mmol/L, (3)
HDL < 1.03 mmol/L in men, < 1.29 mmol/L in women, (4) SBP ≥ 130mmHg or DBP ≥ 85mmHg, and (5) FG ≥ 5.60 mmol/L.
^ Logistic regression model with RDW Quartile 1 as reference, including no covariates
$ Logistic regression model with RDW Quartile 1 as reference, including age, BMI, TC, LDL, RBC, HB, TBIL,BUN, MCV,WBC and MCHC as covariates
*P < 0.05
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